Ultragenyx Pharmaceutical
RARE
#3226
Rank
C$4.75 B
Marketcap
$50.62
Share price
2.77%
Change (1 day)
-16.04%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2023 (TTM): -$13.85

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$14.13. In 2022 the company made an earnings per share (EPS) of -$13.95 a decrease over its 2021 EPS that were of -$9.26.

EPS history for Ultragenyx Pharmaceutical from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$13.85-0.74%
2022-$13.9550.67%
2021-$9.26113.69%
2020-$4.33-55.9%
2019-$9.8382.56%
2018-$5.38-45.15%
2017-$9.8114.68%
2016-$8.5657.36%
2015-$5.4469.83%
2014-$3.2015.22%
2013-$2.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.07-107.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.88-93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.89-72.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.94-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA